Picture this: a 28-year-old software engineer in Pune avoids short sleeves all year, even in 40°C heat, because of the thick, silvery patches on his elbows. A homemaker in Kolkata quietly changes her sari every time white flakes appear on the dark fabric — praying her mother-in-law doesn't notice. Psoriasis is not contagious, not dangerous in the way cancer is, and yet it quietly dismantles the confidence and quality of life of an estimated 2–3 crore Indians. Most of them have never received a correct diagnosis, and fewer still know that 2026 treatment options can bring many patients to near-complete skin clearance.
This guide explains what psoriasis is, why Indians are uniquely affected, and what your treatment options look like — from basic topical creams available at any chemist shop to cutting-edge biologics now increasingly available in Indian cities.
What Is Psoriasis? Understanding the Basics
Psoriasis is a chronic, immune-mediated skin disease — not an infection, not an allergy, and absolutely not contagious. The immune system mistakenly attacks healthy skin cells, triggering them to multiply up to 10 times faster than normal. The result is a build-up of skin cells that pile up on the surface, forming the characteristic red, thickened plaques covered with silvery-white scales.
Psoriasis follows a relapsing-remitting course: flares alternate with periods of remission (sometimes complete clearance). The disease is lifelong, but with the right management, most patients can achieve excellent control.
Types of Psoriasis
| Type | Appearance | Common in India |
|---|---|---|
| Plaque psoriasis | Raised red patches with silver scales on elbows, knees, scalp, lower back | Most common — 80–90% of cases |
| Guttate psoriasis | Small, drop-shaped lesions, often after streptococcal throat infection | Common in children and young adults |
| Pustular psoriasis | White pustules (non-infective) surrounded by red skin | Less common; can be severe |
| Erythrodermic psoriasis | Near-total body skin redness and scaling | Rare; medical emergency |
| Palmoplantar psoriasis | Affects palms and soles; may have painful fissures | Common; often disabling for daily work |
| Psoriatic arthritis | Joint pain + skin psoriasis | Affects 10–30% of psoriasis patients |
How Common Is Psoriasis in India?
Studies from the Indian Journal of Dermatology, Venereology and Leprology (IJDVL) report a prevalence of 0.44–2.8% of the Indian population. With India's current population, this translates to roughly 2–3 crore people living with some form of psoriasis.
Key Indian patterns:
- Males are affected more often than females in India (ratio approximately 2:1 to 3:1), unlike many Western populations where the ratio is equal
- Age at onset has two peaks: early-onset (15–30 years) and late-onset (50–60 years)
- Scalp involvement is extremely common in India — often the first affected site and the one most likely to be confused with severe dandruff
- Palmoplantar psoriasis has a particularly high burden among manual labourers and daily-wage workers whose livelihoods depend on their hands
Despite the numbers, psoriasis remains vastly underdiagnosed in India. Many patients spend years being treated for eczema, fungal infections, or "dry skin" before a dermatologist correctly identifies the condition.
Recognising Psoriasis: Symptoms to Know
Psoriasis lesions have distinct features that distinguish them from other skin conditions:
- Sharply defined, raised plaques with a dry, silvery-white scale — unlike eczema, which tends to ooze and crust
- A characteristic silver shimmer when you gently scrape the scale (called the Auspitz sign, where pinpoint bleeding appears underneath)
- Itching and burning — variable; some patients have severe itch, others have none
- Nail changes: pitting (small depressions), onycholysis (nail lifting off the bed), or brown-yellow "oil spots" under the nail in up to 80% of patients with moderate-severe disease
- Joint pain and swelling in fingers, toes, or the spine in those with psoriatic arthritis
Common Sites in Indian Patients
The elbows, knees, scalp, lower back, and the umbilical region are the most commonly affected areas. However, psoriasis can also affect genitals, skin folds (inverse psoriasis), and the entire body.
Indian-Specific Triggers: What Worsens Psoriasis?
Psoriasis flares in response to certain triggers — and India has a unique profile:
- Stress — the number one trigger in most Indian surveys. Academic pressure, family conflict, work deadlines, and financial stress are consistently reported as the leading precipitants
- Streptococcal throat infections — very common in Indian children; these frequently trigger guttate psoriasis
- Certain medications — beta-blockers (Atenolol, Metoprolol), lithium, antimalarials (hydroxychloroquine), and NSAIDs like ibuprofen can worsen psoriasis
- Alcohol — a significant trigger; binge-drinking, common in urban India, is strongly associated with flares
- Skin trauma — cuts, insect bites, sunburns, and abrasions can trigger new lesions at the injury site (the Koebner phenomenon)
- Infections — HIV, which has a growing burden in India, is associated with severe treatment-resistant psoriasis
- Weather extremes — many Indian patients notice worsening in winter (dry, cold air) and improvement in summer with sun exposure; a minority worsen with heat
Diagnosis: How Is Psoriasis Confirmed?
Psoriasis is primarily a clinical diagnosis — meaning a trained dermatologist can usually identify it by examining your skin. Skin biopsy (a small tissue sample) is reserved for atypical cases to rule out other conditions like eczema, fungal infections, or rare skin disorders.
Lab Tests Your Doctor May Order
While you cannot diagnose psoriasis through a blood test, your doctor will order baseline investigations to:
- Rule out other conditions (KFT, CBC for anaemia if erythrodermic)
- Before starting systemic treatment: CBC, LFT, KFT, fasting blood glucose, HbA1c, hepatitis B (HBsAg) and C (Anti-HCV) screening, chest X-ray (mandatory before biologics in India to rule out latent TB)
- Monitor for drug toxicity during treatment
Track all your psoriasis monitoring tests — CBC, LFT, KFT — in MedicalVault. Having your report history in one place helps your dermatologist spot early trends before they become problems.
The PASI Score: Measuring Disease Severity
The Psoriasis Area and Severity Index (PASI) is the gold-standard tool dermatologists use to measure how severe your psoriasis is and track your response to treatment. It scores:
- Erythema (redness)
- Induration (thickness)
- Desquamation (scaling) across four body regions (head, trunk, upper limbs, lower limbs)
| PASI Score | Severity | Usual Treatment Approach |
|---|---|---|
| < 10 | Mild | Topical therapy alone |
| 10–20 | Moderate | Topical + phototherapy or systemic |
| > 20 | Severe | Systemic therapy or biologics |
A PASI 75 response (75% reduction in PASI score) has traditionally been the benchmark for treatment success. With newer biologics, the target has shifted to PASI 90 or even PASI 100 (near-complete clearance).
Treatment Options in India: From Basic to Biologics
Treatment is chosen based on the severity of your psoriasis, affected sites, and your individual circumstances (pregnancy, kidney disease, TB history, etc.).
Step 1: Topical Therapy (Mild Psoriasis)
For mild psoriasis — limited plaques on elbows, knees, or scalp — topical treatments are the first line:
- Topical corticosteroids (clobetasol propionate, betamethasone): Potent creams or ointments applied directly to plaques. Common Indian brands include Tenovate, Betnovate, and Dermovate. Effective for short-term use; must not be applied to the face or skin folds without medical advice
- Calcipotriol (Daivonex, Psorolin): A vitamin D analogue that slows skin cell growth. Gentler than steroids; safe for face and folds. Often combined with betamethasone (combination products: Xamiol, Daivobet)
- Coal tar preparations: Old but still effective; reduce scaling and inflammation. Available as shampoos (Selsun, Pragtar) and creams
- Salicylic acid: Helps remove thick scale before applying other treatments; available in many over-the-counter formulations
Important: Do NOT use over-the-counter steroid creams unsupervised for long periods. Prolonged misuse causes skin thinning, stretch marks, and steroid-induced skin rebound — making psoriasis dramatically worse.
Step 2: Phototherapy (Moderate Psoriasis)
Narrowband UVB (NB-UVB) phototherapy is the first-line treatment for moderate psoriasis in India and is available at most major dermatology departments in government hospitals and many private clinics.
- Sessions are typically 3 times per week for 12–24 weeks
- Government hospital cost: ₹100–₹300 per session; private clinics: ₹300–₹800 per session
- Highly effective, particularly for guttate psoriasis and body plaque disease
- Safe in children and pregnancy (with modifications)
PUVA therapy (psoralen + UVA) is older and now less preferred due to higher long-term skin cancer risk.
Step 3: Systemic Therapy (Moderate-Severe Psoriasis)
When topical therapy and phototherapy are insufficient, or for extensive disease, dermatologists prescribe systemic medications:
| Drug | How It Works | Monitoring Required | Key Considerations for India |
|---|---|---|---|
| Methotrexate (MTX) | Reduces immune cell activity | CBC, LFT every 3–4 months; avoid alcohol | First-line systemic; cost ₹50–₹200/month; widespread experience; TB screening needed |
| Cyclosporine | Suppresses T-cell activation | KFT, blood pressure monthly | Fast-acting; max 1–2 years; avoid in diabetes and hypertension |
| Acitretin | Vitamin A derivative; reduces skin cell turnover | LFT, lipid profile | Highly teratogenic (not for women of childbearing age); useful in pustular psoriasis |
| Apremilast (Otezla) | PDE4 inhibitor; oral tablet | Minimal lab monitoring | Well-tolerated; cost ₹8,000–₹15,000/month; no TB screening needed |
MTX remains the workhorse of psoriasis treatment in India due to its low cost, decades of experience, and efficacy. However, hepatotoxicity (liver damage) is a real risk, making regular LFT monitoring — which you can easily track in MedicalVault's trend analysis — essential.
Step 4: Biologics (Severe Psoriasis or Treatment Failure)
Biologics represent the most significant advance in psoriasis treatment in decades. These are injectable medicines that target specific molecules involved in the psoriasis immune response.
Biologics available in India for psoriasis:
| Biologic | Target | Route | Frequency | Approximate Cost in India |
|---|---|---|---|---|
| Secukinumab (Cosentyx) | IL-17A | Injection | Monthly (after induction) | ₹25,000–₹40,000/month |
| Adalimumab (Humira, biosimilars: Exemptia, Zulivia) | TNF-alpha | Injection | Every 2 weeks | ₹12,000–₹25,000/month |
| Etanercept (Etacept) | TNF-alpha | Injection | Weekly | ₹10,000–₹20,000/month |
| Ixekizumab (Taltz) | IL-17A | Injection | Monthly | ₹35,000–₹50,000/month |
| Ustekinumab (Stelara) | IL-12/23 | Injection | Every 12 weeks | ₹60,000–₹90,000/dose |
Critical pre-biologic screening in India: Given India's high TB burden, all patients must have a chest X-ray and Mantoux/IGRA test before starting biologics. Active or latent TB must be treated first. Patients on biologics must also be screened for Hepatitis B (HBsAg) as biologics can reactivate HBV infection.
Biosimilars: India has approved adalimumab biosimilars (Exemptia by Zydus, Zulivia by Lupin) that are significantly more affordable than the original Humira — an important access breakthrough for Indian patients.
PM-JAY (Ayushman Bharat) does not currently cover outpatient biologics, but patients hospitalised for severe erythrodermic or pustular psoriasis may be covered for inpatient management.
Psoriatic Arthritis: When Your Joints Are Involved
Psoriatic arthritis (PsA) affects 10–30% of psoriasis patients. It causes pain, swelling, and stiffness in joints — most often the fingers, toes (the characteristic "sausage digit"), wrists, knees, and spine. Crucially, PsA can develop before skin psoriasis in some patients, making diagnosis tricky.
If you have psoriasis and also experience:
- Morning stiffness lasting more than 30 minutes
- Swollen fingers or toes
- Heel pain (enthesitis)
- Lower back pain with stiffness
...ask your dermatologist for a rheumatology referral. An RA Factor (RF) and Anti-CCP test, along with imaging, help distinguish PsA from other forms of arthritis. See our guide on Rheumatoid Arthritis for more context on inflammatory arthritis tests.
Living Well with Psoriasis in India: Practical Tips
Diet and Indian Foods
No single food "cures" psoriasis, but dietary patterns influence inflammation:
- Anti-inflammatory foods to increase: Turmeric (the curcumin in haldi has genuine anti-inflammatory evidence), omega-3-rich fish (mackerel, sardines, rohu), amla, spinach, and flaxseeds
- Foods to limit: High-glycaemic foods (maida, white rice in excess), deep-fried snacks, alcohol, and processed packaged foods
- Maintain a healthy weight: Obesity is a known worsening factor for psoriasis and reduces biologic response
Mental Health Support
Psoriasis has a profound psychological impact. Studies from India consistently show that depression and anxiety are 2-3 times more common in psoriasis patients than in the general population. The stigma — colleagues asking "is it contagious?", relatives suggesting home remedies that worsen the condition — adds to this burden.
Speak openly with your dermatologist about psychological distress. Cognitive behavioural therapy (CBT), stress reduction techniques, and psoriasis patient support groups (available through the Psoriasis Society of India) can meaningfully improve both mental wellbeing and skin outcomes.
Key Takeaways
- Psoriasis is an immune-mediated, non-contagious skin disease affecting an estimated 2–3 crore Indians, yet it remains widely misdiagnosed and stigmatised
- Diagnosis is primarily clinical — a dermatologist can usually confirm it by examination; the PASI score measures severity
- Mild psoriasis responds well to topical steroids and calcipotriol; moderate-severe disease may need phototherapy, systemic drugs (methotrexate, cyclosporine), or biologics
- Methotrexate is the most widely used systemic agent in India for its low cost; regular CBC and LFT monitoring is mandatory
- Before starting biologics in India, TB screening (chest X-ray + Mantoux/IGRA) and Hepatitis B testing are non-negotiable
- Secukinumab and adalimumab biosimilars are now available in India, making biologics more accessible
- Psoriasis is associated with heart disease, diabetes, and psoriatic arthritis — regular metabolic monitoring matters
- Track your psoriasis-related blood tests — CBC, LFT, KFT, lipid profile — on MedicalVault to monitor treatment safety over time
- Consult a dermatologist before starting or stopping any treatment; do not self-medicate with steroid creams long-term